--- Chain 6 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 4063
Reasoning Tokens (Counted): 3458
Non-Reasoning Tokens (Counted): 603
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, let me try to figure this out. Hmm, so the question is about a genetic construct and why there's no green signal observed in the mice. Let's break it down step by step.

First, I need to understand the setup. The researchers created a bicistronic lox-Cre vector. Bicistronic means it has two ORFs, right? So the ligand is at the 5' position, fused to mCherry, and the receptor is at the 3' with eGFP at the C-terminus. The ligand is under the CBA promoter, which I think is a strong promoter, possibly constitutive. Upstream of the receptor is an IRES element, which allows internal ribosome entry, so the receptor can be translated after the ligand.

The stop cassettes are a bit tricky. Between the ligand ORF and mCherry, there's a loxP-stop-loxP cassette. Similarly, the receptor and eGFP have a lox2272-stop-lox2272 cassette. I remember that loxP sites are recognition sites for Cre recombinase. When Cre is present, it excises the stop cassette, allowing the downstream gene to be expressed.

So, in the absence of Cre, the ligand should be expressed because the stop cassette is in front of mCherry, but the stop is in a loxP cassette. Wait, no, wait. The ligand ORF is fused to mCherry, but between them is a stop in a loxP cassette. So normally, without Cre, the stop would prevent mCherry from being expressed. Similarly for the receptor and eGFP.

But when Cre is introduced, it should remove the stop cassettes. For the ligand, since the stop is loxP, Cre would cut and remove it, allowing mCherry to be expressed. For the receptor, it's lox2272, which I think is a variant of the loxP site but recognized by Cre as well. Wait, no, lox2272 is a mutant site that Cre can only recognize when paired with loxP. So if the Cre is of a certain type, but I think in this case, the researchers are using SOX10-Cre, which is a tissue-specific Cre, perhaps in the neural crest.

So when they breed the mice homozygous for the construct to SOX10-Cre hemizygous mice, the Cre should excise the stop cassettes in the cells where SOX10 is expressedâ€”like neural crest derivatives, which includes astrocytes, maybe.

Now, the problem is that after the offspring are born, they don't show a green signal under the confocal. The green is from eGFP. So why wouldn't eGFP be expressed?

Looking at the options:

A) Ligand and receptor are paracrine. Hmm, paracrine means they act on nearby cells. But the question is about expression of receptor-eGFP. So if they're paracrine, the ligand from other cells would activate the receptor here. But why would that affect the expression of eGFP? If the construct isn't working, maybe the eGFP isn't being expressed regardless of ligand-receptor interaction. So I don't think A is the main issue here.

B) Receptor-eGFP stuck in Golgi. That's a trafficking issue. So the eGFP is made but not reaching the cell surface or membrane. But why would this happen specifically? The construct's design could influence this. If the eGFP is after the receptor, maybe the signal peptide or something is missing. Or perhaps the stop cassette wasn't properly removed. Wait, but if the stop was removed by Cre, it should be expressed.

C) Enhancer for expression missing. The ligand is under CBA promoter, which is strong. The receptor is under IRES. So if the enhancer is missing, maybe the IRES isn't working. But the vector design would have the necessary elements, unless the CBA doesn't include an enhancer. But I'm not sure. Alternatively, perhaps the expression isn't happening because the Cre isn't active, so the stop cassettes aren't removed. Wait, but the mice were crossed with SOX10-Cre, which is supposed to activate the Cre in the right cells.

D) Receptor and eGFP not in frame. Oh, that makes sense. If the receptor and eGFP are in the same reading frame, then the eGFP would be expressed as a fusion protein. If they are not in frame, the eGFP won't be produced correctly. But looking at the construct, the receptor ORF is at the 3' and fused to eGFP at the C-terminus. Wait, no, the way it's written is that the receptor is at the 3', and the eGFP is at the C-terminus. So the eGFP is after the receptor. Oh wait, the ORF for the receptor would be followed by eGFP, but with a stop in between. So the stop is in a lox2272 cassette. So when Cre is present, the stop is removed, allowing the receptor and eGFP to be expressed as a single ORF. Wait, that's not right. The setup is that the receptor has its own ORF, and after it, there's the eGFP, but the stop is in a lox2272 cassette. So the lox2272 is between the receptor and eGFP.

Wait, no. Let me clarify: the vector is bicistronic. The ligand is first, then a stop cassette (loxP), then mCherry. Then the IRES, then the receptor, then a stop cassette (lox2272), then eGFP.

Wait, no. Wait, the question says: ligand ORF is at 5', fused to mCherry. Then between ligand ORF and mCherry is a stop in a loxP cassette. So the ligand is expressed as a fusion with mCherry? No, wait, the ORF is the ligand, then after the ligand stop, mCherry might be under another promoter? No, probably, in a bicistronic vector, they're both under a single promoter.

Wait, I'm getting confused. Let's re-express the construct: it's a bicistronic construct, meaning two ORFs in the same transcript. The first ORF is the ligand, followed by a stop cassette (loxP-stop-loxP). Then, after that, mCherry. Wait, but that would mean that without Cre, the ligand is expressed, but mCherry is not. Because the stop is in between, so the transcript would be ligand followed by stop, preventing mCherry expression. When Cre is present, the stop is removed, so mCherry is expressed in frame with the ligand? Or is it a separate expression?

Wait, perhaps the loxP-stop-loxP is a cassette that, when Cre is present, is excised, so the transcript continues beyond the ligand ORF, allowing mCherry to be expressed. So ligand is expressed as a fusion with mCherry. Similarly, for the receptor, the IRES is upstream, so the second ORF is receptor, followed by a stop cassette (lox2272), then eGFP. So when Cre is present, the stop is excised, and the eGFP is expressed as a fusion with the receptor.

Wait, but the question says the ligand is under the CBA promoter. So the ligand is at 5', with the receptor downstream. The CBA promoter is strong, and the IRES allows the receptor to be expressed as a second ORF.

So the presence of Cre would remove the stop cassettes, leading to mCherry after ligand, and eGFP after receptor.

In the offspring, they're using SOX10-Cre, which is activated in neural crest cells and their derivatives, including perhaps astrocytes. So in those cells, the Cre should excise the stop cassettes, meaning both mCherry and eGFP should be expressed.

But in the experiment, the eGFP isn't being visualized. So why?

Looking at option D: the receptor and eGFP are not in frame. So, if the stop cassette is removed but the eGFP is not in frame with the receptor, it might not be expressed. Wait, no, because the eGFP would be downstream of the receptor. If they are in the same frame, then the receptor-eGFP would be a fusion protein. If not in frame, then the eGFP won't be expressed. Wait, but the way it's designed, the eGFP is meant to be expressed as a separate ORF, right? Because IRES allows internal ribosome entry, so the receptor is expressed, and then the eGFP is expressed as a separate ORF. Hmm, maybe not. Or perhaps it's a single transcript with IRES elements. Wait, actually, in a bicistronic construct, the first ORF is under the promoter, and the second uses an IRES to allow ribosome binding without another promoter. So the receptor would be expressed after the ligand.

But wait, the vector is designed with the ligand ORF, then stop cassette, then mCherry. Then IRES, then receptor ORF, then stop cassette, then eGFP.

Wait, perhaps the mCherry is under the same promoter as the ligand, but the stop is in between. So without Cre, the ligand is expressed, but mCherry isn't. With Cre, the stop is removed, so the transcript continues, and mCherry is expressed. Similarly, for the receptor and eGFP: the receptor is under the same promoter, but the stop is in between, so eGFP is only expressed when Cre removes the stop.

But perhaps the eGFP is in frame with the receptor, so the eGFP would be a fusion. Or maybe it's a separate ORF after the IRES.

Wait, the question says the receptor is at the 3' and fused to eGFP at the C-terminus. So the eGFP is a C-terminal tag. So the construct is receptor-eGFP as a single ORF, but only when the stop is removed.

So if the stop is removed (lox2272 cassette), the eGFP would be in frame, assuming that the stop is right after the receptor ORF. So when Cre excises the stop, the eGFP is expressed as part of the same ORF. But if the reading frame is not correct, the eGFP won't be expressed.

So if the eGFP is in a different frame, the stop cassette would not be correctly excised, or the eGFP would not be a functional tag.

So if the eGFP is not in frame, then the fusion would not be correct, and perhaps the eGFP isn't expressed, so no green signal.

Alternatively, the problem could be that the stop cassettes weren't excised because Cre wasn't active. But they used SOX10-Cre, which should be active in the relevant cells. Also, the Western blot was done on primary astrocyte culture, and the proteins were expressed as expected, perhaps. The question says that after transfecting the plasmid into astrocytes and using the antibodies, the Western blot showed signals proportional to actin loading. So the construct was expressing the proteins, indicating that the stop cassettes were correctly excised.

Wait, but in the mice, they cross to SOX10-Cre. So perhaps the Cre isn't active in the cells where the construct is being expressed. Maybe the construct is expressed in a different cell type than where SOX10-Cre is active. Or perhaps the Cre isn't expressed at the right time or place.

Alternatively, perhaps the enhancer or promoter for the construct isn't active, so the ligand and receptor aren't being expressed. But the ligand is under the CBA promoter, which is strong, so that's probably not it.

Another possibility is that the loxP and lox2272 sites aren't correctly recognized by the Cre used. But lox2272 is a mutant site that requires Cre with a certain mutation; I think in some cases, lox2272 cannot be recombined unless paired with another lox2272 or a loxP. Wait, no, lox2272 is a site that Cre can recognize but only when paired with another lox2272 or a loxP. So perhaps in the vector, the ligand has a loxP stop cassette, and the receptor has a lox2272 stop cassette. If the Cre can only recognize one type, but that's not the case. SOX10-Cre is a wild-type Cre, so it should recognize both loxP and lox2272 sites.

Wait, but I'm a bit confused about how the lox2272 works. So loxP is 34 bp, and lox2272 is a variant that Cre can only recombine when paired with another lox2272. Or is it that Cre can recombine lox2272 with loxP? I think Cre can recombine lox2272 with loxP. Because lox2272 is a mutant version that has an extra base pair, but Cre still recognizes it when paired with a loxP site. So if the vector has a loxP and a lox2272 site, Cre should be able to excise both.

So in the mice, the Cre should excise both stop cassettes. So why isn't eGFP being expressed?

Another angle: the eGFP is not being translated correctly. If the reading frame is wrong after the stop cassette is removed, the eGFP wouldn't be expressed. So if the receptor ORF ends, and the eGFP starts, but not in the same frame, then the eGFP won't be expressed. That's option D.

Alternatively, perhaps the IRES isn't working, so the receptor isn't expressed. But the IRES is supposed to allow the second ORF to be expressed. Or maybe the IRES is tissue-specific, but I think the question states that the vector is a bicistronic lox-Cre vector, so the IRES is functional.

Wait, but the problem says that in the mice, after crossing to SOX10-Cre, the eGFP isn't expressed. So perhaps the issue is with the construct in the mice, not the culture. But in the culture, the Western blot shows the proteins are expressed, suggesting that the stop cassettes were correctly removed.

Hmm. Let me think of each option again.

Option D says the receptor and eGFP are not in frame. So the eGFP is not part of the same ORF as the receptor. If the stop is removed, but the eGFP is in a different frame, then the eGFP won't be translated. So the eGFP won't fluoresce. That would explain the lack of green signal.

Alternatively, if the eGFP is out of frame, it might not be expressed, so no signal. So that's a possibility.

Option C says the enhancer for expression is missing. But the ligand is under CBA, which is a strong promoter, so expression shouldn't be the issue. The IRES should allow the receptor to be expressed as a second ORF.

Option B: stuck in the Golgi. That would prevent the eGFP from being on the cell surface, but if the eGFP is cytoplasmic, perhaps it's not fluorescent. But why would only eGFP be stuck? The mCherry would be expressed as well, but the question is about the green signal.

But the question says they're looking for eGFP. So if the eGFP is not expressed, that's the issue.

So, the most likely answer is D: the receptor and eGFP are not in frame, so the eGFP isn't expressed.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector designed to express a ligand and receptor pair. The ligand is at the 5' position, fused to mCherry, and the receptor is at the 3' position, fused to eGFP. The ligand is under the CBA promoter, and the receptor is preceded by an IRES element. Stop cassettes (loxP-stop-loxP for the ligand-mCherry and lox2272-stop-lox2272 for the receptor-eGFP) are present, which can be excised by Cre recombinase to allow expression of the downstream genes.

The experiment involves crossing mice homozygous for the construct with SOX10-Cre hemizygous mice. SOX10-Cre is expected to excise the stop cassettes in neural crest-derived cells, enabling expression of mCherry and eGFP. However, no green signal from eGFP is observed under confocal microscopy. The possible reasons for this outcome are analyzed as follows:

1. **Option A (Ligand and receptor are in a paracrine relationship):**  
   A paracrine relationship describes ligand-receptor interactions between nearby cells. However, this does not explain the lack of eGFP expression, as the issue is with the construct itself, not the mode of interaction. This option is unlikely.

2. **Option B (Receptor-eGFP construct is stuck in the Golgi):**  
   If the receptor-eGFP construct were stuck in the Golgi, it would fail to reach the cell surface, preventing fluorescence. However, the Western blot confirmed proper expression of the proteins in primary astrocyte culture, indicating that the construct is functional and traffics correctly. This option is unlikely.

3. **Option C (Enhancer for ligand and receptor expression is missing):**  
   The ligand is under the strong CBA promoter, and the receptor is driven by an IRES element, which should allow expression. The absence of an enhancer is unlikely to be the issue, as the construct was shown to express proteins in culture. This option is unlikely.

4. **Option D (Receptor and eGFP are not in frame):**  
   If the receptor and eGFP are not in the same reading frame, the eGFP would not be expressed correctly. The construct design specifies that the eGFP is fused to the receptor at the C-terminus. If the stop cassette was excised but the eGFP is out of frame, it would fail to produce a functional eGFP protein, resulting in no green signal. This explanation aligns with the observed lack of fluorescence and is the most likely reason.

Based on the analysis, the most plausible explanation is that the receptor and eGFP are not in frame, preventing proper expression of eGFP.

Answer: D